These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2035776)

  • 1. The neuromuscular blocking effect of Org 9426. A new intermediately-acting steroidal non-depolarising muscle relaxant in man.
    Booij LH; Knape HT
    Anaesthesia; 1991 May; 46(5):341-3. PubMed ID: 2035776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical observations on the neuromuscular blocking action of Org 9426, a new steroidal non-depolarizing agent.
    Wierda JM; de Wit AP; Kuizenga K; Agoston S
    Br J Anaesth; 1990 Apr; 64(4):521-3. PubMed ID: 2334630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular effects of rocuronium bromide (Org 9426) during fentanyl and halothane anaesthesia.
    Cooper RA; Mirakhur RK; Maddineni VR
    Anaesthesia; 1993 Feb; 48(2):103-5. PubMed ID: 8460753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and neuromuscular effects of three steroidal neuromuscular blocking drugs in dogs (ORG 9616, ORG 9426, ORG 9991).
    Cason B; Baker DG; Hickey RF; Miller RD; Agoston S
    Anesth Analg; 1990 Apr; 70(4):382-8. PubMed ID: 1969251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of neuromuscular action of rocuronium, a new steroidal non-depolarizing agent, with vecuronium.
    Lin PL; Liu CC; Fan SZ; Chao A; Shin SC; Tai YT
    Acta Anaesthesiol Sin; 1997 Sep; 35(3):127-31. PubMed ID: 9407675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset and recovery of rocuronium (Org 9426) and vecuronium under enflurane anaesthesia.
    Mayer M; Doenicke A; Hofmann A; Peter K
    Br J Anaesth; 1992 Nov; 69(5):511-2. PubMed ID: 1361356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
    Kim KS; Chun YS; Chon SU; Suh JK
    Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of action and intubating conditions following vecuronium, rocuronium and mivacurium.
    Wierda JM; Hommes FD; Nap HJ; van den Broek L
    Anaesthesia; 1995 May; 50(5):393-6. PubMed ID: 7793541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of intubating conditions after administration of Org 9246 (rocuronium) and suxamethonium.
    Cooper R; Mirakhur RK; Clarke RS; Boules Z
    Br J Anaesth; 1992 Sep; 69(3):269-73. PubMed ID: 1389845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rocuronium bromide in dental day case anaesthesia--a comparison with atracurium and vecuronium.
    Chetty MS; Pollard BL; Wilson A; Healy TE
    Anaesth Intensive Care; 1996 Feb; 24(1):37-41. PubMed ID: 8669652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a new neuromuscular blocking agent (Org 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations.
    Muir AW; Houston J; Green KL; Marshall RJ; Bowman WC; Marshall IG
    Br J Anaesth; 1989 Oct; 63(4):400-10. PubMed ID: 2573387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of neuromuscular blocking agents in patients undergoing renal transplantation under general anesthesia.
    Ma H; Zhuang X
    Chin Med J (Engl); 2002 Nov; 115(11):1692-6. PubMed ID: 12609090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the dose-response and time course of recovery of atracurium and rocuronium.
    Xue F; Zhang Y; Liao X; Liu J; An G
    Chin Med J (Engl); 2000 Nov; 113(11):1019-21. PubMed ID: 11776116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular and cardiovascular effects of atracurium during nitrous oxide-fentanyl and nitrous oxide-isoflurane anaesthesia.
    Rupp SM; Fahey MR; Miller RD
    Br J Anaesth; 1983; 55 Suppl 1():67S-70S. PubMed ID: 6688020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
    Arain SR; Kern S; Ficke DJ; Ebert TJ
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
    Naguib M; Abdulatif M; al-Ghamdi A
    Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of neuromuscular effects, efficacy and safety of rocuronium and atracurium in ambulatory anaesthesia.
    Whalley DG; Maurer WG; Knapik AL; Estafanous FG
    Can J Anaesth; 1998 Oct; 45(10):954-9. PubMed ID: 9836032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine.
    Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
    Br J Anaesth; 1995 Nov; 75(5):588-92. PubMed ID: 7577286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative pre- and postjunctional effects of a new vecuronium analogue, Org 9426, at the rat neuromuscular junction.
    Tian L; Mehta MP; Prior C; Marshall IG
    Br J Anaesth; 1992 Sep; 69(3):284-7. PubMed ID: 1356399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.